Wolf H Fridman

24PUBLICATIONS
76CO-AUTHORS
HaematologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 04, 2026
Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeleton.

Mikel Rezola Artero, Andrea Minery, Margot Revel

|Aug 05, 2025
High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Lucía Carril-Ajuria, Ronan Flippot, Marie Naigeon

|Jan 23, 2025
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma.

Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su

|Sep 22, 2023
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.

Teresa Maria Rosaria Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso

|Jun 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.

Guillaume Davidson, Alexandra Helleux, Yann A Vano

|Nov 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.

Xiaofan Lu, Yann Vano, Alexandra Helleux

Pageof 4

Frequent Collaborators

11 joint publications

Wolf Herve Fridman

8 joint publications

Lubka T Roumenina

8 joint publications

Florent Petitprez

5 joint publications

Maxime Meylan